According to a new report in The American Journal of Medicine, aspirin can be considered an effective and safe option to other, more expensive medications to treat acute migraines as well as prevent recurrent attacks. A review ...
Dec 3, 2019
0
9
Aspirin could be used to treat the world's deadliest infectious disease, according to new research conducted by Dr. Elinor Hortle at the Centenary Institute in Sydney.
Nov 29, 2019
0
5
Researchers conducted a database search to investigate whether aspirin can aid in the prevention of intracranial aneurysm rupture by hindering aneurysm growth. The researchers identified 146 patients harboring multiple intracranial ...
Oct 29, 2019
0
7
If you've never had a heart attack or stroke, you likely should not be taking aspirin to prevent them, according to new research.
Oct 2, 2019
0
4
(HealthDay)—Ticagrelor alone results in less bleeding than ticagrelor plus aspirin among high-risk patients who have undergone percutaneous coronary intervention (PCI) and received dual antiplatelet therapy for three months, ...
Sep 27, 2019
0
2
Low-dose aspirin may improve survival odds for patients battling head/neck and lung cancer, two new studies suggest.
Sep 23, 2019
0
2
(HealthDay)—Patients with chronic coronary artery disease or peripheral artery disease treated with the combination of rivaroxaban and aspirin face a greater risk for bleeding versus patients treated with aspirin alone, ...
Sep 17, 2019
0
4
The benefits of aspirin may outweigh the risks for many patients without known cardiovascular disease (CVD). Such patients could be identified by using a personalized benefit-harm analysis, which could inform discussions ...
Sep 17, 2019
0
2
In late-breaking clinical trial results presented in a Hot Line Session today at the European Society of Cardiology Congress 2019, investigators from Brigham and Women's Hospital and Greater Paris University Hospitals—AP-HP/Université ...
Sep 1, 2019
0
53
Low-dose aspirin does not prolong disability-free survival of healthy people over 70, even in those at the highest risk of cardiovascular disease. The late breaking results of the ASPREE trial are presented today at ESC Congress ...
Aug 31, 2019
0
41
